Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Cidara Therapeutics Inc (CDTX)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Cidara Therapeutics Inc's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
11.810 -0.170    -1.42%
01/05 - Closed. Currency in USD ( Disclaimer )
After Hours
11.520
-0.290
-2.456%
23:33:52 - Real-time Data
  • Volume: 107,662
  • Bid/Ask: 11.510 / 11.800
  • Day's Range: 11.016 - 11.860
Type:  Equity
Market:  United States
Cidara Therapeutics Inc 11.810 -0.170 -1.42%

CDTX Share Price Overview

 
Assess today's live Cidara Therapeutics Inc (CDTX) share price, performance and insights using our live NASDAQ: CDTX stock exchange data.

Analyse the historical data and Cidara Therapeutics Inc share price performance charts on this page. Our technical summary section provides analysis on Cidara Therapeutics Inc share price buy/sell indicators using real-time data (or discuss the Cidara Therapeutics Inc (CDTX) stock price today with other investors in the Cidara Therapeutics Inc NASDAQ share price and sentiment chat forum).

Use the dropdown to select a relevant stock exchange for the current NASDAQ CDTX share price (ISIN: US1717572069) to enhance your trading decisions with our free investment tools and resources.

What Is the Cidara Therapeutics Inc Share Price Today?
The Cidara Therapeutics Inc share price today is 11.810.

What Is the Stock Symbol for Cidara Therapeutics Inc
The stock symbol (or 'ticker') for Cidara Therapeutics Inc is "CDTX."

What Stock Exchange Does Cidara Therapeutics Inc Trade On?
Cidara Therapeutics Inc is listed and trades on the NASDAQ stock exchange.

Is Cidara Therapeutics Inc a Good Stock to Buy?
Determining whether Cidara Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Prev. Close11.98
Day's Range11.016 - 11.86
Revenue63.91M
Open11.85
52 wk Range10.004 - 29.6
EPS - 5.25
Volume107,662
Market Cap53.87M
Dividend (Yield)N/A (N/A)
Average Volume (3m)60,056
P/E Ratio - 2.25
Beta1.01
1-Year Change - 42.11%
Shares Outstanding4,561,751
Next Earnings DateMay 09, 2024
What is your sentiment on Cidara Therapeutics Inc?
or
Market is currently closed. Voting is open during market hours.

Cidara Therapeutics Inc News Today


Technical Summary

Type 5 Min 15 Min Hourly Daily Monthly
Moving Averages Buy Buy Sell Strong Sell Strong Sell
Technical Indicators Strong Buy Strong Buy Sell Strong Sell Strong Sell
Summary Strong Buy Strong Buy Sell Strong Sell Strong Sell

Candlestick Patterns

 

Filter Table By:

Candle Sticks Characteristics:

Time Frame
Type
Pattern Indication
Reliability
Pattern Timeframe Reliability Candles Ago Candle Time
Emerging Patterns
Harami Cross 5H Current
Bullish doji Star 1D Current
Completed Patterns
Doji Star Bearish 15 3 May 01, 2024 20:00
Bullish Engulfing 5H 4 Apr 30, 2024 14:00
Bullish Engulfing 1M 5 Dec 23

Trending Stocks

Create Alert
Add to Watchlist
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

  Name Last High Low Chg. Chg. % Vol. Time
  HSBC 697.50 703.40 693.20 +1.90 +0.27% 11.39M  
  GSK plc 1,705.00 1,718.50 1,673.00 +32.00 +1.91% 5.85M  
  Lloyds Banking 52.20 52.84 51.90 +0.30 +0.58% 90.40M  
  Rolls-Royce Holdings 407.50 417.40 407.50 -5.60 -1.36% 18.46M  
  BT Group 103.85 109.07 102.80 +1.25 +1.22% 25.27M  
  Aston Martin Lagonda 138.20 144.20 128.00 -10.00 -6.75% 2.86M  
  Vodafone Group PLC 67.480 69.320 67.400 -0.180 -0.27% 26.96M  
  BP 509.40 521.80 508.50 -11.00 -2.11% 20.71M  
  IAG 173.05 175.75 172.30 -2.05 -1.17% 3.89M  
  Barclays 203.45 205.28 198.84 +0.75 +0.37% 79.05M  

%SHORT_NAME% Company Profile

IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

73

Equity Type

ORD

Cidara Therapeutics, Inc., a biotechnology company, focuses on developing targeted therapies for patients facing cancers and other serious diseases. The company’s product includes rezafungin acetate, a novel molecule in the echinocandin class of antifungals for the treatment and prevention of invasive fungal infections, including candidemia and invasive candidiasis, which are fungal infections associated with high mortality rates. It also develops its Cloudbreak platform that enables development of novel drug-Fc conjugates, that includes CD388, a potent antiviral designed to deliver universal prevention and treatment of seasonal and pandemic influenza, which is in Phase 1 and Phase 2a clinical trials. The company was formerly known as K2 Therapeutics, Inc. and changed its name to Cidara Therapeutics, Inc. in July 2014. The company was incorporated in 2012 and is based in San Diego, California.

Read More
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

CDTX Price Commentary

Write your thoughts about Cidara Therapeutics Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email